250 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Hjärpe J, Söderman E, Andreou D, Sedvall GC, Agartz I, Jönsson EG. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals. Psychiatry Research. 263: 30-34. PMID 29482043 DOI: 10.1016/j.psychres.2018.02.036  0.4
2016 Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG. Associations between a locus downstream DRD1 gene and cerebrospinal fluid dopamine metabolite concentrations in psychosis. Neuroscience Letters. PMID 26957229 DOI: 10.1016/j.neulet.2016.03.005  0.4
2015 Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis. Psychiatry Research. 229: 497-504. PMID 26142836 DOI: 10.1016/j.psychres.2015.06.023  1
2013 Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker WW, Kahn RS. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 196-204. PMID 22647933 DOI: 10.1016/j.euroneuro.2012.04.019  1
2012 Andreou D, Saetre P, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG. D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians. European Archives of Psychiatry and Clinical Neuroscience. 262: 549-56. PMID 22454242 DOI: 10.1007/s00406-012-0313-z  1
2011 Andreou D, Saetre P, Kähler AK, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 21: 700-4. PMID 21295953 DOI: 10.1016/j.euroneuro.2010.12.008  1
2010 Andreou D, Saetre P, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG. Tryptophan hydroxylase gene 1 (TPH1) variants associated with cerebrospinal fluid 5-hydroxyindole acetic acid and homovanillic acid concentrations in healthy volunteers. Psychiatry Research. 180: 63-7. PMID 20580984 DOI: 10.1016/j.psychres.2009.11.018  1
2010 Annerbrink K, Jönsson EG, Olsson M, Nilsson S, Sedvall GC, Anckarsäter H, Eriksson E. Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and monoamine metabolite concentrations in cerebrospinal fluid. Psychiatry Research. 179: 231-4. PMID 20483169 DOI: 10.1016/j.psychres.2009.04.018  1
2008 Jönsson EG, Saetre P, Edman-Ahlbom B, Sillén A, Gunnar A, Andreou D, Agartz I, Sedvall G, Hall H, Terenius L. Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 1695-9. PMID 18781277 DOI: 10.1007/s00702-008-0113-9  1
2007 Sedvall G. A quest for antipsychotic drug actions in the brain: personal experiences from 50 years of neuropsychiatric research at Karolinska Institutet. Physiology & Behavior. 92: 238-44. PMID 17631363 DOI: 10.1016/j.physbeh.2007.05.060  1
2006 Vares M, Ekholm A, Sedvall GC, Hall H, Jönsson EG. Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures. Psychopathology. 39: 286-95. PMID 16960467 DOI: 10.1159/000095733  1
2006 Laywer G, Nyman H, Agartz I, Arnborg S, Jönsson EG, Sedvall GC, Hall H. Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression. Bmc Psychiatry. 6: 31. PMID 16901336 DOI: 10.1186/1471-244X-6-31  1
2006 Agartz I, Sedvall GC, Terenius L, Kulle B, Frigessi A, Hall H, Jönsson EG. BDNF gene variants and brain morphology in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 141: 513-23. PMID 16741916 DOI: 10.1002/ajmg.b.30338  1
2006 Jönsson EG, Edman-Ahlbom B, Sillén A, Gunnar A, Kulle B, Frigessi A, Vares M, Ekholm B, Wode-Helgodt B, Schumacher J, Cichon S, Agartz I, Sedvall GC, Hall H, Terenius L. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 30: 924-33. PMID 16581172 DOI: 10.1016/j.pnpbp.2006.02.008  1
2005 Tamagaki C, Sedvall GC, Jönsson EG, Okugawa G, Hall H, Pauli S, Agartz I. Altered white matter/gray matter proportions in the striatum of patients with schizophrenia: a volumetric MRI study. The American Journal of Psychiatry. 162: 2315-21. PMID 16330596 DOI: 10.1176/appi.ajp.162.12.2315  1
2005 Ekholm B, Ekholm A, Adolfsson R, Vares M, Osby U, Sedvall GC, Jönsson EG. Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nordic Journal of Psychiatry. 59: 457-64. PMID 16316898 DOI: 10.1080/08039480500360906  1
2005 Fleischhacker WW, Keet IPM, Kahn RS, Hummer M, Peuskens J, Hranov LG, Libiger J, Dollfus S, Gaebel W, Davidson M, Galderisi S, Boter H, Rybakowski J, Gheorghe M, Ibor JJL, ... Sedvall G, et al. The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial Schizophrenia Research. 78: 147-156. PMID 16055308 DOI: 10.1016/j.schres.2005.06.004  1
2005 Glaser B, Schumacher J, Williams HJ, Jamra RA, Ianakiev N, Milev R, Ohlraun S, Schulze TG, Czerski PM, Hauser J, Jönsson EG, Sedvall GC, Klopp N, Illig T, Becker T, et al. No association between the putative functional ZDHHC8 single nucleotide polymorphism rs175174 and schizophrenia in large European samples. Biological Psychiatry. 58: 78-80. PMID 15992527 DOI: 10.1016/j.biopsych.2005.03.017  1
2004 Jönsson EG, Bah J, Melke J, Abou Jamra R, Schumacher J, Westberg L, Ivo R, Cichon S, Propping P, Nöthen MM, Eriksson E, Sedvall GC. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Bmc Psychiatry. 4: 4. PMID 15102340 DOI: 10.1186/1471-244X-4-4  1
2004 Damberg M, BerggÃ¥rd C, Farde L, Sedvall GC, Jönsson EG. Transcription factor AP-2beta genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 537-45. PMID 15057523 DOI: 10.1007/s00702-003-0097-4  1
2003 Williams NM, Norton N, Williams H, Ekholm B, Hamshere ML, Lindblom Y, Chowdari KV, Cardno AG, Zammit S, Jones LA, Murphy KC, Sanders RD, McCarthy G, Gray MY, Jones G, ... ... Sedvall G, et al. A systematic genomewide linkage study in 353 sib pairs with schizophrenia. American Journal of Human Genetics. 73: 1355-67. PMID 14628288 DOI: 10.1086/380206  1
2003 Van Den Bogaert A, Schumacher J, Schulze TG, Otte AC, Ohlraun S, Kovalenko S, Becker T, Freudenberg J, Jönsson EG, Mattila-Evenden M, Sedvall GC, Czerski PM, Kapelski P, Hauser J, Maier W, et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. American Journal of Human Genetics. 73: 1438-43. PMID 14618545 DOI: 10.1086/379928  1
2003 Jönsson EG, Abou Jamra R, Schumacher J, Flyckt L, Edman G, Forslund K, Mattila-Evenden M, Rylander G, Asberg M, Bjerkenstedt L, Wiesel FA, Propping P, Cichon S, Nöthen MM, Sedvall GC. No association between a putative functional promoter variant in the dopamine beta-hydroxylase gene and schizophrenia. Psychiatric Genetics. 13: 175-8. PMID 12960750 DOI: 10.1097/01.ypg.0000066964.66429.ce  1
2003 Okugawa G, Sedvall GC, Agartz I. Smaller cerebellar vermis but not hemisphere volumes in patients with chronic schizophrenia. The American Journal of Psychiatry. 160: 1614-7. PMID 12944335 DOI: 10.1176/appi.ajp.160.9.1614  1
2003 Carmine A, Buervenich S, Galter D, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Chowdari KV, Nimgaonkar VL, Anvret M, Sydow O, Olson L. NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 120: 51-7. PMID 12815740 DOI: 10.1002/ajmg.b.20033  1
2003 Jönsson EG, Sillén A, Vares M, Ekholm B, Terenius L, Sedvall GC. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 119: 28-34. PMID 12707934 DOI: 10.1002/ajmg.b.20004  1
2003 Jönsson EG, Sedvall GC, Nöthen MM, Cichon S. Dopamine D4 receptor gene (DRD4) variants and schizophrenia: meta-analyses. Schizophrenia Research. 61: 111-9. PMID 12648742 DOI: 10.1016/S0920-9964(02)00287-6  1
2003 Jönsson EG, Norton N, Forslund K, Mattila-Evenden M, Rylander G, Asberg M, Owen MJ, Sedvall GC. Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. Schizophrenia Research. 61: 31-7. PMID 12648733 DOI: 10.1016/S0920-9964(02)00224-4  1
2003 Carmine A, Chheda MG, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Anvret M, Buervenich S, Olson L. Two NOTCH4 polymorphisms and their relation to schizophrenia susceptibility and different personality traits. Psychiatric Genetics. 13: 23-8. PMID 12605097 DOI: 10.1097/01.ypg.0000056680.82896.22  1
2003 Jönsson EG, Flyckt L, Burgert E, Crocq MA, Forslund K, Mattila-Evenden M, Rylander G, Asberg M, Nimgaonkar VL, Edman G, Bjerkenstedt L, Wiesel FA, Sedvall GC. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatric Genetics. 13: 1-12. PMID 12605094 DOI: 10.1097/01.ypg.0000051094.88669.4b  1
2002 Jönsson EG, Damberg M, Forslund K, Mattila-Evenden M, Rylander G, Asberg M, Oreland L, Sedvall GC. No association between a transcription factor Activating Protein 2beta (AP-2beta) gene variant and schizophrenia. Neuroscience Letters. 330: 290-2. PMID 12270648 DOI: 10.1016/S0304-3940(02)00818-2  1
2002 Okugawa G, Sedvall GC, Agartz I. Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 252: 120-3. PMID 12192469 DOI: 10.1007/s00406-002-0370-9  1
2002 Karlsson P, Farde L, Halldin C, Sedvall G. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. The American Journal of Psychiatry. 159: 761-7. PMID 11986129 DOI: 10.1176/appi.ajp.159.5.761  1
2002 Okugawa G, Sedvall G, Nordström M, Andreasen N, Pierson R, Magnotta V, Agartz I. Selective reduction of the posterior superior vermis in men with chronic schizophrenia. Schizophrenia Research. 55: 61-7. PMID 11955964 DOI: 10.1016/S0920-9964(01)00248-1  1
2002 Sedvall GC. Internationalization of psychiatric research - the prospective for the European Association of Psychiatrists. Acta Psychiatrica Scandinavica. 105: 321-3. PMID 11942938 DOI: 10.1034/j.1600-0447.2002.2e004.x  1
2002 Arnborg S, Agartz I, Hall H, Jönsson E, Sillén A, Sedvall G. Data mining in schizophrenia research - Preliminary analysis Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2431: 27-38.  1
2001 Agartz I, Okuguwa G, Nordström M, Greitz D, Magnotta V, Sedvall G. Reliability and reproducibility of brain tissue volumetry from segmented MR scans. European Archives of Psychiatry and Clinical Neuroscience. 251: 255-61. PMID 11881838  1
2001 Vawter MP, Usen N, Thatcher L, Ladenheim B, Zhang P, VanderPutten DM, Conant K, Herman MM, van Kammen DP, Sedvall G, Garver DL, Freed WJ. Characterization of human cleaved N-CAM and association with schizophrenia. Experimental Neurology. 172: 29-46. PMID 11681838 DOI: 10.1006/exnr.2001.7790  1
2001 Varnäs K, Hall H, Bonaventure P, Sedvall G. Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743. Brain Research. 915: 47-57. PMID 11578619 DOI: 10.1016/S0006-8993(01)02823-2  1
2001 Jönsson EG, Ivo R, Forslund K, Mattila-Evenden M, Rylander G, Cichon S, Propping P, Nöthen MM, Asberg M, Sedvall GC. No association between a promoter dopamine D(4) receptor gene variant and schizophrenia. American Journal of Medical Genetics. 105: 525-8. PMID 11496369 DOI: 10.1002/ajmg.1478  1
2001 Hurd YL, Suzuki M, Sedvall GC. D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain. Journal of Chemical Neuroanatomy. 22: 127-37. PMID 11470560 DOI: 10.1016/S0891-0618(01)00122-3  1
2001 Jönsson EG, Nöthen MM, Gustavsson JP, BerggÃ¥rd C, Bunzel R, Forslund K, Rylander G, Mattila-Evenden M, Propping P, Asberg M, Sedvall G. No association between serotonin 2A receptor gene variants and personality traits. Psychiatric Genetics. 11: 11-7. PMID 11409694 DOI: 10.1097/00041444-200103000-00003  1
2001 Buervenich S, Xiang F, Sydow O, Jönsson EG, Sedvall GC, Anvret M, Olson L. Identification of four novel polymorphisms in the calcitonin/alpha-CGRP (CALCA) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression. Human Mutation. 17: 435-6. PMID 11317366 DOI: 10.1002/humu.1126  1
2001 Nobuhara K, Farde L, Halldin C, Karlsson P, Swahn CG, Olsson H, Bergström KA, Larsson SA, Schnell PO, McPherson DW, Savonen A, Hiltunen J, Sedvall G. SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP. European Journal of Nuclear Medicine. 28: 13-24. PMID 11202446 DOI: 10.1007/s002590000390  1
2001 Jönsson EG, Nöthen MM, Gustavsson JP, Berggård C, Bunzel R, Forslund K, Rylander G, Mattila-Evenden M, Propping P, Åsberg M, Sedvall G. Association study between 5-HT2a polymorphisms and personality traits American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 626.  1
2001 Jönsson EG, Ivo R, Forslund K, Mattila-Evenden M, Rylander G, Cichon S, Propping P, Nöthen MM, Åsberg M, Sedvall GC. No association between DRD4-521C/T variant and schizophrenia American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 618.  1
2001 Hall H, Hurd Y, Pauli S, Halldin C, Sedvall G. Human brain imaging post-mortem - Whole hemisphere technologies International Review of Psychiatry. 13: 12-17.  1
2000 Buervenich S, Carmine A, Arvidsson M, Xiang F, Zhang Z, Sydow O, Jönsson EG, Sedvall GC, Leonard S, Ross RG, Freedman R, Chowdari KV, Nimgaonkar VL, Perlmann T, Anvret M, et al. NURR1 mutations in cases of schizophrenia and manic-depressive disorder. American Journal of Medical Genetics. 96: 808-13. PMID 11121187 DOI: 10.1002/1096-8628(20001204)96:6<808::AID-AJMG23>3.0.CO;2-E  1
2000 Hall H, Farde L, Halldin C, Lundkvist C, Sedvall G. Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907. Synapse (New York, N.Y.). 38: 421-31. PMID 11044889 DOI: 10.1002/1098-2396(20001215)38:4<421::AID-SYN7>3.0.CO;2-X  1
2000 Mirsky AF, Bieliauskas LA, French LM, Van Kammen DP, Jönsson E, Sedvall G. A 39-year followup of the Genain quadruplets. Schizophrenia Bulletin. 26: 699-708. PMID 10993407  1
2000 Jönsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC. A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Journal of Psychiatric Research. 34: 239-44. PMID 10867119 DOI: 10.1016/S0022-3956(00)00013-3  1
2000 Nobuhara K, Halldin C, Hall H, Karlsson P, Farde L, Hiltunen J, McPherson DW, Savonen A, Bergström KA, Pauli S, Swahn CG, Larsson SA, Schnell PO, Sedvall G. Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease. Psychopharmacology. 149: 45-55. PMID 10789882  1
2000 Sedvall G, Terenius L. Editorial Brain Research Reviews. 31: 105. DOI: 10.1016/S0165-0173(99)00026-0  1
1999 Jönsson EG, Nöthen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden M, Asberg M, Propping P, Sedvall GC. Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia. Schizophrenia Research. 40: 31-6. PMID 10541004 DOI: 10.1016/S0920-9964(99)00033-X  1
1999 Hurd YL, Keller E, Sotonyi P, Sedvall G. Preprotachykinin-A mRNA expression in the human and monkey brain: An in situ hybridization study. The Journal of Comparative Neurology. 411: 56-72. PMID 10404107 DOI: 10.1002/(SICI)1096-9861(19990816)411:1<56::AID-CNE5>3.0.CO;2-3  1
1999 Gustavsson JP, Nöthen MM, Jönsson EG, Neidt H, Forslund K, Rylander G, Mattila-Evenden M, Sedvall GC, Propping P, Asberg M. No association between serotonin transporter gene polymorphisms and personality traits. American Journal of Medical Genetics. 88: 430-6. PMID 10402513 DOI: 10.1002/(SICI)1096-8628(19990820)88:4<430::AID-AJMG23>3.0.CO;2-1  1
1999 Jönsson EG, Nimgaonkar VL, Zhang XR, Shaw SH, Burgert E, Crocq MA, Chakravarti A, Sedvall GC. Trend for an association between schizophrenia and D3S1310, a marker in proximity to the dopamine D3 receptor gene. American Journal of Medical Genetics. 88: 352-7. PMID 10402502 DOI: 10.1002/(SICI)1096-8628(19990820)88:4<352::AID-AJMG12>3.0.CO;2-0  1
1999 Jönsson EG, Nöthen MM, Grünhage F, Farde L, Nakashima Y, Propping P, Sedvall GC. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molecular Psychiatry. 4: 290-6. PMID 10395223  1
1999 Sandell J, Halldin C, Hall H, Thorberg SO, Werner T, Sohn D, Sedvall G, Farde L. Radiosynthesis and autoradiographic evaluation of [11C]NAD-299, a radioligand for visualization of the 5-HT1A receptor. Nuclear Medicine and Biology. 26: 159-64. PMID 10100214 DOI: 10.1016/S0969-8051(98)00091-2  1
1999 Hall H, Halldin C, Guilloteau D, Chalon S, Emond P, Besnard J, Farde L, Sedvall G. Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I. Neuroimage. 9: 108-16. PMID 9918732 DOI: 10.1006/nimg.1998.0366  1
1999 Sedvall GC, Karlsson P. Pharmacological manipulation of D1-dopamine receptor function in schizophrenia Neuropsychopharmacology. 21: S181-S188. DOI: 10.1016/S0893-133X(99)00104-9  1
1998 Halldin C, Foged C, Chou YH, Karlsson P, Swahn CG, Sandell J, Sedvall G, Farde L. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 39: 2061-8. PMID 9867142  1
1998 Hall H, Halldin C, Farde L, Sedvall G. Whole hemisphere autoradiography of the postmortem human brain. Nuclear Medicine and Biology. 25: 715-9. PMID 9863555 DOI: 10.1016/S0969-8051(98)00053-5  1
1998 Caberlotto L, Fuxe K, Rimland JM, Sedvall G, Hurd YL. Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain. Neuroscience. 86: 167-78. PMID 9692752 DOI: 10.1016/S0306-4522(98)00039-6  1
1998 Jönsson EG, Geijer T, Gyllander A, Terenius L, Sedvall GC. Failure to replicate an association between a rare allele of a tyrosine hydroxylase gene microsatellite and schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 248: 61-3. PMID 9684913 DOI: 10.1007/s004060050018  1
1998 Jönsson EG, Nöthen MM, Gustavsson JP, Neidt H, Bunzel R, Propping P, Sedvall GC. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Psychiatry Research. 79: 1-9. PMID 9676821 DOI: 10.1016/S0165-1781(98)00027-4  1
1998 Jönsson EG, Dahl ML, Roh HK, Jerling M, Sedvall GC. Lack of association between debrisoquine 4-hydroxylase (CYP2D6) gene polymorphisms and schizophrenia. Psychiatric Genetics. 8: 25-8. PMID 9564684  1
1998 Jönsson EG, Zhang F, Nimgaonkar VL, Rudert WA, Sedvall GC. Lack of association between schizophrenia and HLA DQB1 alleles in a Swedish sample. Schizophrenia Research. 29: 293-6. PMID 9516671 DOI: 10.1016/S0920-9964(97)00104-7  1
1998 Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Research. 779: 58-74. PMID 9473588 DOI: 10.1016/S0006-8993(97)01078-0  1
1998 Jönsson EG, Nöthen MM, Neidt H, Farde L, Propping P, Sedvall GC. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density in vivo of healthy volunteers American Journal of Medical Genetics - Neuropsychiatric Genetics. 81: 497.  1
1998 Jönsson EG, Nöthen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden MM, Åsberg M, Propping P, Sedvall GC. Association between a promoter poly-morphism in the dopamine D2 receptor gene and schizophrenia American Journal of Medical Genetics - Neuropsychiatric Genetics. 81: 497.  1
1997 Jönsson EG, Goldman D, Spurlock G, Gustavsson JP, Nielsen DA, Linnoila M, Owen MJ, Sedvall GC. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. European Archives of Psychiatry and Clinical Neuroscience. 247: 297-302. PMID 9477008  1
1997 Jönsson EG, Härnryd C, Johannesson T, Wahlström J, Bergenius J, Bergstedt H, Greitz D, Nyman H, Björck E, Blennow E, Sedvall GC. Further studies on a male monozygotic triplet with schizophrenia: cytogenetical and neurobiological assessments in the patients and their parents. European Archives of Psychiatry and Clinical Neuroscience. 247: 239-47. PMID 9444492  1
1997 Jönsson EG, Mirsky AF, Johannesson T, Wahlström J, Bieliauskas LA, van Kammen DP, Sedvall GC. No cytogenetical abnormalities in a set of schizophrenic quadruplets. Biological Psychiatry. 42: 1186-7. PMID 9426891  1
1997 Svenningsson P, Hall H, Sedvall G, Fredholm BB. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse (New York, N.Y.). 27: 322-35. PMID 9372555 DOI: 10.1002/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E  1
1997 Günther I, Hall H, Halldin C, Swahn CG, Farde L, Sedvall G. [125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain. Nuclear Medicine and Biology. 24: 629-34. PMID 9352533 DOI: 10.1016/S0969-8051(97)00081-4  1
1997 Geijer T, Jönsson E, Neiman J, Gyllander A, Sedvall G, Rydberg U, Terenius L. Prodynorphin allelic distribution in Scandinavian chronic alcoholics. Alcoholism, Clinical and Experimental Research. 21: 1333-6. PMID 9347097  1
1997 Hall H, Halldin C, Jerning E, Osterlund M, Farde L, Sedvall G. Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors. Nuclear Medicine and Biology. 24: 389-93. PMID 9290072 DOI: 10.1016/S0969-8051(97)00016-4  1
1997 Thome J, Jönsson E, Foley P, Harsányi A, Sedvall G, Riederer P. Ciliary neurotrophic factor null mutation and schizophrenia in a Swedish population. Psychiatric Genetics. 7: 79-82. PMID 9285965  1
1997 Caberlotto L, Fuxe K, Sedvall G, Hurd YL. Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum. The European Journal of Neuroscience. 9: 1212-25. PMID 9215705  1
1997 Jŏnsson E, Brené S, Zhang XR, Nimgaonkar VL, Tylec A, Schalling M, Sedvall G. Schizophrenia and neurotrophin-3 alleles. Acta Psychiatrica Scandinavica. 95: 414-9. PMID 9197906  1
1997 Sedvall GC. [Promising effects of the new antipsychotic agents in schizophrenia. But recommendations of the Medical Products Agency are conservative]. LäKartidningen. 94: 1873-6. PMID 9190476  1
1997 Pauli S, Sedvall G. Three-dimensional visualization and quantification of the benzodiazepine receptor population within a living human brain using PET and MRI. European Archives of Psychiatry and Clinical Neuroscience. 247: 61-70. PMID 9177951  1
1997 Jönsson EG, Nöthen MM, Gustavsson JP, Neidt H, Brené S, Tylec A, Propping P, Sedvall GC. Lack of evidence for allelic association between personality traits and the dopamine D4 receptor gene polymorphisms. The American Journal of Psychiatry. 154: 697-9. PMID 9137132  1
1997 Ginovart N, Lundin A, Farde L, Halldin C, Bäckman L, Swahn CG, Pauli S, Sedvall G. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain : a Journal of Neurology. 120: 503-14. PMID 9126061 DOI: 10.1093/brain/120.3.503  1
1997 Geijer T, Jönsson E, Neiman J, Persson ML, Brené S, Gyllander A, Sedvall G, Rydberg U, Wasserman D, Terenius L. Tyrosine hydroxylase and dopamine D4 receptor allelic distribution in Scandinavian chronic alcoholics. Alcoholism, Clinical and Experimental Research. 21: 35-9. PMID 9046370  1
1997 Hall H, Lundkvist C, Halldin C, Farde L, Pike VW, McCarron JA, Fletcher A, Cliffe IA, Barf T, Wikström H, Sedvall G. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Research. 745: 96-108. PMID 9037397 DOI: 10.1016/S0006-8993(96)01131-6  1
1996 Oxenstierna G, Bergstrand G, Edman G, Flyckt L, Nybäck H, Sedvall G. Increased frequency of aberrant CSF circulation in schizophrenic patients compared to healthy volunteers. European Psychiatry : the Journal of the Association of European Psychiatrists. 11: 16-20. PMID 19698417 DOI: 10.1016/0924-9338(96)80454-8  1
1996 Hall H, Halldin C, Dijkstra D, Wikström H, Wise LD, Pugsley TA, Sokoloff P, Pauli S, Farde L, Sedvall G. Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907. Psychopharmacology. 128: 240-7. PMID 8972543 DOI: 10.1007/s002130050131  1
1996 Jönsson E, Sedvall G, Brené S, Gustavsson JP, Geijer T, Terenius L, Crocq MA, Lannfelt L, Tylec A, Sokoloff P, Schwartz JC, Wiesel FA. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biological Psychiatry. 40: 1032-43. PMID 8915563 DOI: 10.1016/0006-3223(95)00581-1  1
1996 Jönsson E, Brené S, Geijer T, Terenius L, Tylec A, Persson ML, Sedvall G. A search for association between schizophrenia and dopamine-related alleles. European Archives of Psychiatry and Clinical Neuroscience. 246: 297-304. PMID 8908411 DOI: 10.1007/BF02189022  1
1996 Jönsson E, Lannfelt L, Engvall B, Sedvall G. Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele. European Archives of Psychiatry and Clinical Neuroscience. 246: 182-4. PMID 8832195 DOI: 10.1007/BF02188951  1
1996 Jönsson E, Brené S, Lindblad K, Sharara S, Sedvall G, Schalling M. Lack of expansion of cytosine adenine guanine trinucleotide repeat in the dentatorubral and pallidoluysian atrophy gene in Swedish schizophrenic patients. Biological Psychiatry. 40: 228-9. PMID 8830958 DOI: 10.1016/0006-3223(96)00037-6  1
1996 Sedvall GC. Neurobiological correlates of acute neuroleptic treatment. International Clinical Psychopharmacology. 11: 41-6. PMID 8803659 DOI: 10.1097/00004850-199605002-00007  1
1996 Dean CE, Nordstrom AL, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G. Unique receptor-blockading profile of clozapine [15] American Journal of Psychiatry. 153: 1239-1240. PMID 8780446  1
1996 Hall H, Farde L, Halldin C, Hurd YL, Pauli S, Sedvall G. Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride. Synapse (New York, N.Y.). 23: 115-23. PMID 8723716 DOI: 10.1002/(SICI)1098-2396(199606)23:2<115::AID-SYN7>3.0.CO;2-C  1
1996 Jönsson E, Nöthen MM, Bunzel R, Propping P, Sedvall G. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 347: 1831. PMID 8667938  1
1996 Malhotra AK, Goldman D, Buchanan R, Breier A, Pickar D. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 347: 1830-1. PMID 8667937 DOI: 10.1016/S0140-6736(96)91650-5  1
1996 Lidén S, Reizenstein P, Sedvall G, Ehn L. [A study and treatment of a group of patients with electro-hypersensitivity. More than half of the patients were able to return to work]. LäKartidningen. 93: 2265-8. PMID 8649122  1
1996 Sedvall G, Farde L. Dopamine receptors in schizophrenia. Lancet. 347: 264. PMID 8551909  1
1995 Sedvall G, Pauli S, Karlsson P, Farde L, Nordström AL, Nyberg S, Halldin C. PET imaging of neuroreceptors in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 25-30. PMID 8775755 DOI: 10.1016/0924-977X(95)00021-G  1
1995 Jönsson E, Björck E, Wahlström J, Gustavsson P, Sedvall G. Screening for CGG trinucleotide repeat expansion in the fragile X mental retardation 1 gene in schizophrenic patients. Psychiatric Genetics. 5: 157-60. PMID 8750357  1
1995 Karlsson P, Smith L, Farde L, Härnryd C, Sedvall G, Wiesel FA. Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients. Psychopharmacology. 121: 309-16. PMID 8584611 DOI: 10.1007/BF02246068  1
1995 Karlsson P, Sedvall G, Halldin C, Swahn CG, Farde L. Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man. Psychopharmacology. 121: 300-8. PMID 8584610 DOI: 10.1007/BF02246067  1
1995 Härnryd C, Jönsson E, Greitz D, Nyman H, Sedvall G. A set of male monozygotic triplets with schizophrenic psychoses: nature or nurture? European Archives of Psychiatry and Clinical Neuroscience. 245: 1-7. PMID 7786906 DOI: 10.1007/BF02191537  0.32
1995 Angst J, Borbely A, Engel RR, Ferner U, Gaszner P, Hippius H, Lader M, Lingjaerde O, Rüther E, Rzwuska M. Report on the sixth consensus conference on the methodology of clinical trials with hypnotic drugs. Pharmacopsychiatry. 28: 2-7. PMID 7746840 DOI: 10.1055/s-2007-979580  1
1995 Jönsson E, Forsell C, Lannfelt L, Sedvall G. Schizophrenia and APP gene mutations. Biological Psychiatry. 37: 135-6. PMID 7718679 DOI: 10.1016/0006-3223(94)00211-K  1
1995 Karlsson P, Farde L, Halldin C, Sedvall G, Ynddal L, Sloth-Nielsen M. Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man. Psychopharmacology. 119: 1-8. PMID 7675940 DOI: 10.1007/BF02246046  1
1995 Sedvall G, Farde L. Chemical brain anatomy in schizophrenia. Lancet. 346: 743-9. PMID 7658878 DOI: 10.1016/S0140-6736(95)91508-7  1
1995 Sedvall G, Pauli S, Farde L, Karlsson P, Nyberg S, Nordström AL. Recent developments in PET scan imaging of neuroreceptors in schizophrenia. The Israel Journal of Psychiatry and Related Sciences. 32: 22-9. PMID 7622344  1
1995 Sedvall G, Farde L, Hall H, Halldin C, Karlsson P, Nordström AL, Nyberg S, Pauli S. Utilization of radioligands in schizophrenia research. Clinical Neuroscience (New York, N.Y.). 3: 112-21. PMID 7583617  1
1995 Nordström AL, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. The American Journal of Psychiatry. 152: 1444-9. PMID 7573582  1
1995 Hall H, Halldin C, Nyberg S, Farde L, Sedvall G. Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 19-25. PMID 7542051 DOI: 10.1016/0924-977X(94)00127-W  1
1995 Brené S, Hall H, Lindefors N, Karlsson P, Halldin C, Sedvall G. Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors. Neuroscience. 67: 37-48. PMID 7477907 DOI: 10.1016/0306-4522(95)00037-J  1
1995 Farde L, Nordstrom AL, Karlsson P, Halldin C, Sedvall G, Sethy, Schwartz JC, Von Voigtlander. Positron emission tomography studies on dopamine receptors in schizophrenia Clinical Neuropharmacology. 18: S121-S129.  1
1994 Sedvall G, Karlsson P, Lundin A, Anvret M, Suhara T, Halldin C, Farde L. Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease. European Archives of Psychiatry and Clinical Neuroscience. 243: 249-55. PMID 8172940 DOI: 10.1007/BF02191583  1
1994 Brené S, Lindefors N, Ehrlich M, Taubes T, Horiuchi A, Kopp J, Hall H, Sedvall G, Greengard P, Persson H. Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 985-98. PMID 8120638  1
1994 Farde L, Pauli S, Litton JE, Halldin C, Neiman J, Sedvall G. PET-determination of benzodiazepine receptor binding in studies on alcoholism. Exs. 71: 143-53. PMID 8032146  1
1994 Farde L, Nordström AL, Nyberg S, Halldin C, Sedvall G. D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients. The Journal of Clinical Psychiatry. 55: 67-9. PMID 7961577  1
1994 Sedvall G. [Image processing in psychiatry--a review]. Fortschritte Der Neurologie-Psychiatrie. 62: 39-43. PMID 7959526  1
1994 Geijer T, Neiman J, Rydberg U, Gyllander A, Jönsson E, Sedvall G, Valverius P, Terenius L. Dopamine D2-receptor gene polymorphisms in Scandinavian chronic alcoholics. European Archives of Psychiatry and Clinical Neuroscience. 244: 26-32. PMID 7918698 DOI: 10.1007/BF02279808  1
1994 Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 11: 245-56. PMID 7531978 DOI: 10.1038/sj.npp.1380111  1
1994 Swahn CG, Halldin C, Farde L, Karlsson P, Sedvall G. Metabolism in human plasma determined by HPLC for five 11C-labelled benzazepines-radioligands for PET examination of the dopamine D-1 receptor Journal of Labelled Compounds and Radiopharmaceuticals. 35: 540-542.  1
1994 Halidin C, Swahn CG, Suhara T, Farde L, Karlsson P, Sokoloff P, Sedvall G. Preparation of (+)-[propyl-11C]7-OH-DPAT, a selective dopamine D-3 receptor agonist for PET Journal of Labelled Compounds and Radiopharmaceuticals. 35: 471-472.  1
1994 Halldin C, Wikstrom H, Swahn CG, Sedvall G, Stjernlof P, Farde L. Preparation of [propyl-11C]OSU 191, a highly potent and selective 5- HT(1A) agonist for PET Journal of Labelled Compounds and Radiopharmaceuticals. 35: 494-495.  1
1994 Swahn CG, Halldin C, Farde L, Sedvall G. Metbabolism of the PET ligand [11C]SCH 23390. Identification of two radiolabelled metabolites with HPLC Human Psychopharmacology. 9: 25-31.  1
1993 Jönsson E, Lannfelt L, Sokoloff P, Schwartz JC, Sedvall G. Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatrica Scandinavica. 87: 345-9. PMID 8517175  1
1993 Hall H, Halldin C, Sedvall G. Binding of [3H]SCH 39166 to human post mortem brain tissue. Pharmacology & Toxicology. 72: 152-8. PMID 8516265  1
1993 Lindefors N, Lindén A, Brené S, Sedvall G, Persson H. CCK peptides and mRNA in the human brain. Progress in Neurobiology. 40: 671-90. PMID 8484007 DOI: 10.1016/0301-0082(93)90010-P  1
1993 Fredrikson M, Wik G, Greitz T, Eriksson L, Stone-Elander S, Ericson K, Sedvall G. Regional cerebral blood flow during experimental phobic fear. Psychophysiology. 30: 126-30. PMID 8416057  1
1993 Litton JE, Neiman J, Pauli S, Farde L, Hindmarsh T, Halldin C, Sedvall G. PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls. Psychiatry Research. 50: 1-13. PMID 8390063  1
1993 Halldin C, Foged C, Farde L, Karlsson P, Hansen K, Grønvald F, Swahn CG, Hall H, Sedvall G. [11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey. Nuclear Medicine and Biology. 20: 945-53. PMID 8298574 DOI: 10.1016/0969-8051(93)90095-C  1
1993 Häfner H, Sedvall G, Angst J. Today's perspective on Kraepelin's nosology of endogenous psychoses European Archives of Psychiatry and Clinical Neuroscience. 243: 164-170. PMID 8117760 DOI: 10.1007/BF02190723  1
1993 Karlsson P, Farde L, Halldin C, Swahn CG, Sedvall G, Foged C, Hansen KT, Skrumsager B. PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor. Psychopharmacology. 113: 149-56. PMID 7855175 DOI: 10.1007/BF02245691  1
1992 Hall H, Halldin C, Sedvall G. Gpp(NH)p stimulates [3H]raclopride binding to homogenates from human putamen and accumbens. Neuroscience Letters. 136: 79-82. PMID 1635671 DOI: 10.1016/0304-3940(92)90652-N  1
1992 Kopp J, Lindefors N, Brené S, Hall H, Persson H, Sedvall G. Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain. Neuroscience. 47: 771-9. PMID 1533704 DOI: 10.1016/0306-4522(92)90028-Z  1
1992 Sedvall G. The current status of PET scanning with respect to schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 7: 41-54. PMID 1388021  1
1992 Hall H, Farde L, Halldin C, Högberg T, Larsson S, Sedvall G. Imaging of dopamine receptors using PET and SPECT. Neurochemistry International. 20: 329S-333S. PMID 1365450 DOI: 10.1016/0197-0186(92)90260-X  1
1992 Farde L, Nordström AL, Halldin C, Wiesel FA, Sedvall G. PET studies of dopamine receptors in relation to antipsychotic drug treatment. Clinical Neuropharmacology. 15: 468A-469A. PMID 1354052  1
1992 Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Archives of General Psychiatry. 49: 538-44. PMID 1352677 DOI: 10.1001/archpsyc.1992.01820070032005  1
1992 Halldin C, Farde L, Litton JE, Hall H, Sedvall G. [11C]Ro 15-4513, a ligand for visualization of benzodiazepine receptor binding. Preparation, autoradiography and positron emission tomography. Psychopharmacology. 108: 16-22. PMID 1329130 DOI: 10.1007/BF02245279  1
1992 Pauli S, Liljequist S, Farde L, Swahn CG, Halldin C, Litton JE, Sedvall G. PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil. Psychopharmacology. 107: 180-5. PMID 1319600 DOI: 10.1007/BF02245135  1
1992 Swahn CG, Farde L, Halldin C, Sedvall G. Ligand metabolites in plasma during PET-studies with the 11C-labelled dopamine antagonists, raclopride, SCH 23390 and N-methylspiroperidol Human Psychopharmacology. 7: 97-103. DOI: 10.1002/hup.470070204  1
1992 Hall H, Litton JE, Halldin C, Kopp J, Sedvall G. Studies on the binding of [3H]flumazenil and [3H]sarmazenil in post-mortem human brain Human Psychopharmacology. 7: 367-377.  1
1992 Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Jönsson E, Sedvall G, Schwartz JC. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders Psychiatric Genetics. 2: 249-256.  1
1992 Sedvall G. Current status of PET scanning in schizophrenia Neuropsychopharmacology. 7: 73-75.  1
1991 Persson A, d'Argy R, Gillberg PG, Halldin C, Litton JE, Swahn CG, Sedvall G. Autoradiography with saturation experiments of 11C-Ro 15-1788 binding to human brain sections. Journal of Neuroscience Methods. 36: 53-61. PMID 2062111 DOI: 10.1016/0165-0270(91)90137-O  1
1991 Lindefors N, Brené S, Kopp J, Lindén A, Brodin E, Sedvall G, Persson H. Distribution of cholecystokinin mRNA and peptides in the human brain. Neuroscience. 42: 813-21. PMID 1956517 DOI: 10.1016/0306-4522(91)90046-Q  1
1991 Angst J, Bech P, Bobon D, Engel R, Hippius H, Janzen GJ, Lecrubier Y, Lingjaerde O, Moller HJ, Montgomery S, Paes de Sousa M, Rossi A, Saletu B, Sedvall G, Stefanis C, et al. Report on the third Consensus Conference on the methodology of clinical trials with antipsychotic drugs Pharmacopsychiatry. 24: 149-152. PMID 1685571  1
1991 Sedvall G, Farde L, Barnett A, Hall H, Halldin C. 11C-SCH 39166, a selective ligand for visualization of dopamine-D1 receptor binding in the monkey brain using PET. Psychopharmacology. 103: 150-3. PMID 1674157 DOI: 10.1007/BF02244195  1
1991 Persson A, d'Argy R, Gillberg PG, Halldin C, Litton JL, Swahn CG, Sedvall G. Autoradiography and saturation experiments with 11C-RO 15-1788 binding to human brain. Acta Radiologica. Supplementum. 376: 169-70. PMID 1666768  1
1991 Halldin C, Farde L, Hall H, Högberg T, Printz G, Pulka W, Sedvall G, Solin O. Synthesis of five benzamide analogs. Comparison with positron emission tomography. Acta Radiologica. Supplementum. 376: 121-2. PMID 1666743  1
1991 Halldin C, Farde L, Barnett A, Sedvall G. Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D-1 receptor ligand, and preliminary PET investigations. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 42: 451-5. PMID 1646191 DOI: 10.1016/0883-2889(91)90105-A  1
1991 Pauli S, Farde L, Halldin C, Sedvall G. Occupancy of the central benzodiazepine receptors during benzodiazepine treatment determined by PET European Neuropsychopharmacology. 1: 229-231. DOI: 10.1016/0924-977X(91)90498-J  1
1991 Duelfer T, Johnstrom P, Stone-Elander S, Holland A, Halldin C, Haaparanta M, Solin O, Bergman J, Steinman M, Sedvall G. The labelling of 2-oxoquazepam with electrophilic 18F Journal of Labelled Compounds and Radiopharmaceuticals. 29: 1223-1239.  1
1991 Halldin C, Farde L, Barnett A, Sedvall G. Synthesis of [11C]SCH 39166, a new selective D-1 dopamine receptor ligand for PET Journal of Labelled Compounds and Radiopharmaceuticals. 30: 349 -350.  1
1990 Gandy SE, Grebb JA, Rosen N, Albert KA, Devinsky O, Blumberg H, Anderson N, Cedarbaum JM, Porter RJ, Sedvall G. General assay for phosphoproteins in cerebrospinal fluid: a candidate marker for paraneoplastic cerebellar degeneration. Annals of Neurology. 28: 829-33. PMID 2285268 DOI: 10.1002/ana.410280616  1
1990 Halldin C, Farde L, Högberg T, Hall H, Sedvall G. Carbon-11 labelling of eticlopride in two different positions--a selective high-affinity ligand for the study of dopamine D-2 receptors using PET. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 41: 669-74. PMID 2170298 DOI: 10.1016/0883-2889(90)90082-R  1
1990 Kopp J, Hall H, Persson A, Sedvall G. Temperature dependence of [3H]Ro 15-1788 binding to benzodiazepine receptors in human postmortem brain homogenates. Journal of Neurochemistry. 55: 1310-5. PMID 2168936  1
1990 Wiesel FA, Farde L, Nordström AL, Sedvall G. Central D1- and D2-receptor occupancy during antipsychotic drug treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 14: 759-67. PMID 1981395 DOI: 10.1016/0278-5846(90)90046-J  1
1990 Sedvall G. Monoamines and schizophrenia. Acta Psychiatrica Scandinavica. Supplementum. 358: 7-13. PMID 1978495  1
1990 Farde L, Wiesel FA, Stone-Elander S, Halldin C, Nordström AL, Hall H, Sedvall G. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. Archives of General Psychiatry. 47: 213-9. PMID 1968328 DOI: 10.1001/archpsyc.1990.01810150013003  1
1990 Sedvall G, Farde L, Nybäck H, Pauli S, Persson A, Savic I, Wiesel FA. Recent advances in psychiatric brain imaging. Acta Radiologica. Supplementum. 374: 113-5. PMID 1966956  1
1990 Sedvall G. PET imaging of dopamine receptors in human basal ganglia: relevance to mental illness. Trends in Neurosciences. 13: 302-8. PMID 1695408 DOI: 10.1016/0166-2236(90)90114-P  1
1990 Sedvall G. Special symposium on Remoxipride: Introduction Acta Psychiatrica Scandinavica, Supplement. 82: 3.  1
1989 Köhler C, Persson A, Melander T, Theodorsson E, Sedvall G, Hökfelt T. Distribution of galanin-binding sites in the monkey and human telencephalon: preliminary observations. Experimental Brain Research. 75: 375-80. PMID 2721615 DOI: 10.1007/BF00247944  1
1989 Grebb JA, Browning MD, Valverius P, Borg S, Sedvall G, Greengard P. An analysis of postmortem brain samples from 32 alcoholic and nonalcoholic individuals for protein III, a neuronal phosphoprotein. Alcoholism, Clinical and Experimental Research. 13: 673-9. PMID 2688467  1
1989 Brené S, Lindefors N, Kopp J, Sedvall G, Persson H. Regional distribution of neuropeptide Y mRNA in postmortem human brain. Brain Research. Molecular Brain Research. 6: 241-9. PMID 2593779 DOI: 10.1016/0169-328X(89)90070-3  1
1989 Nybäck H, Nordberg A, LÃ¥ngström B, Halldin C, Hartvig P, Ahlin A, Swahn CG, Sedvall G. Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. Progress in Brain Research. 79: 313-9. PMID 2587749  1
1989 Farde L, Wiesel FA, Nilsson L, Sedvall G. The potential of positron-emission tomography for pharmacokinetic and pharmacodynamic studies of neuroleptics. Psychopharmacology Series. 7: 32-9. PMID 2574454  1
1989 Sedvall G. Approaches for finding new types of antipsychotic compounds. Acta Psychiatrica Scandinavica. Supplementum. 352: 16-23. PMID 2573237  1
1989 Farde L, Wiesel FA, Nordström AL, Sedvall G. D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology. 99: S28-31. PMID 2573104 DOI: 10.1007/BF00442555  1
1989 Grind M, Nilsson MI, Nilsson L, Oxenstierna G, Sedvall G, Wahlén A. Remoxipride--a new potential antipsychotic compound. Tolerability and pharmacokinetics after single oral and intravenous administration in healthy male volunteers. Psychopharmacology. 98: 304-9. PMID 2568653 DOI: 10.1007/BF00451679  1
1989 Walaas SI, Sedvall G, Greengard P. Dopamine-regulated phosphorylation of synaptic vesicle-associated proteins in rat neostriatum and substantia nigra. Neuroscience. 29: 9-19. PMID 2496331 DOI: 10.1016/0306-4522(89)90328-X  1
1989 Melander T, Bartfai T, Brynne N, Consolo S, Fisone G, Hokfelt T, Kohler C, Nordstrom O, Norheim-Theodorsson E, Persson A, Sedvall G, Staines WA, Wu CF. Galanin in the cholinergic basal forebrain: histochemical, autoradiographic and in vivo studies Progress in Brain Research. 79: 85-91. PMID 2479959  1
1989 Farde L, Wiesel FA, Halldin C, Sedvall G, Nilsson L. Dopamine Receptor Occupancy and Plasma Haloperidol Levels-Reply Archives of General Psychiatry. 46: 483-484. DOI: 10.1001/archpsyc.1989.01810050097022  1
1989 Angst J, Bech P, Boyer P, Bruinvels J, Engel R, Helmchen H, Hippius H, Lingjaerde O, Racagni G, Saletu B, Sedvall G, Silverstone JT, Stefanis CN, Stoll K, Woggon B. Consensus conference on the methodology of clinical trials of antidepressants, Zurich, March 1988: Report of the Consensus Committee Pharmacopsychiatry. 22: 3-7.  1
1989 Persson A, Pauli S, Halldin C, Stone-Elander S, Farde L, Sjogren I, Sedvall G. Saturation analysis of specific 11C Ro 15-1788 binding to the human neocortex using positron emission tomography Human Psychopharmacology. 4: 21-31.  1
1989 Persson A, Pauli S, Swahn CG, Halldin C, Sedvall G. Cerebral uptake of 11C-Ro 15-1788 and its acid metabolite 11C-Ro 15-3890; PET study in healthy volunteers Human Psychopharmacology. 4: 215-220.  1
1988 Hagenfeldt L, Oxenstierna G, Alfredsson G, Edman G, Iselius L, Sedvall G. A twin study of amino acid concentrations in cerebrospinal fluid. Journal of Psychiatric Research. 22: 51-6. PMID 3397910 DOI: 10.1016/0022-3956(88)90028-3  1
1988 Berrettini WH, Oxenstierna G, Sedvall G, Nurnberger JI, Gold PW, Rubinow DR, Goldin LR. Characteristics of cerebrospinal fluid neuropeptides relevant to clinical research. Psychiatry Research. 25: 349-59. PMID 3186863 DOI: 10.1016/0165-1781(88)90104-7  1
1988 Farde L, Wiesel FA, Jansson P, Uppfeldt G, Wahlen A, Sedvall G. An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET. Psychopharmacology. 94: 1-7. PMID 3126517 DOI: 10.1007/BF00735871  1
1988 Sedvall G, Farde L, Hall H, Pauli S, Persson A, Wiesel FA. PET scanning--a new tool in clinical psychopharmacology. Psychopharmacology Series. 5: 27-33. PMID 3045802  1
1988 Hall H, Köhler C, Gawell L, Farde L, Sedvall G. Raclopride, a new selective ligand for the dopamine-D2 receptors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 559-68. PMID 2975809 DOI: 10.1016/0278-5846(88)90001-2  1
1988 Andreasen NC, Carson R, Diksic M, Evans A, Farde L, Gjedde A, Hakim A, Lal S, Nair N, Sedvall G. Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum. Schizophrenia Bulletin. 14: 471-84. PMID 2975043  1
1988 Hall H, Farde L, Sedvall G. Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride. Journal of Neural Transmission. 73: 7-21. PMID 2969950 DOI: 10.1007/BF01244618  1
1988 Savic I, Persson A, Roland P, Pauli S, Sedvall G, Widén L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet (London, England). 2: 863-6. PMID 2902315 DOI: 10.1016/S0140-6736(88)92468-3  1
1988 Farde L, Grind M, Nilsson MI, Ogenstad S, Sedvall G. Remoxipride--a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers. Psychopharmacology. 95: 157-61. PMID 2901121 DOI: 10.1007/BF00174501  1
1988 Farde L, Wiesel FA, Halldin C, Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Archives of General Psychiatry. 45: 71-6. PMID 2892477 DOI: 10.1001/archpsyc.1988.01800250087012  1
1988 Wik G, Borg S, Sjögren I, Wiesel FA, Blomqvist G, Borg J, Greitz T, Nybäck H, Sedvall G, Stone-Elander S. PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose. Acta Psychiatrica Scandinavica. 78: 234-41. PMID 2851920  1
1988 Halldin C, Stone-Elander S, Thorell JO, Persson A, Sedvall G. 11C-labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 39: 993-7. PMID 2848785 DOI: 10.1016/0883-2889(88)90044-5  1
1988 Swahn CG, Sedvall G. CSF creatinine in schizophrenia. Biological Psychiatry. 23: 586-94. PMID 2451543 DOI: 10.1016/0006-3223(88)90005-4  1
1988 Wiesel FA, Farde L, Sedvall G, Wik G. The application of positron emission tomography in psychiatry Nordic Journal of Psychiatry. 42: 107-110. DOI: 10.3109/08039488809103214  1
1987 Lindvall O, Backlund EO, Farde L, Sedvall G, Freedman R, Hoffer B, Nobin A, Seiger A, Olson L. Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Annals of Neurology. 22: 457-68. PMID 3435067 DOI: 10.1002/ana.410220403  1
1987 Jacobson B, Eklund G, Hamberger L, Linnarsson D, Sedvall G, Valverius M. Perinatal origin of adult self-destructive behavior. Acta Psychiatrica Scandinavica. 76: 364-71. PMID 3425362  1
1987 d'Argy R, Persson A, Sedvall G. A quantitative cerebral and whole body autoradiographic study of a intravenously administered benzodiazepine antagonist 3H-Ro 15-1788 in mice. Psychopharmacology. 92: 8-13. PMID 3037585 DOI: 10.1007/BF00215472  1
1987 Farde L, Halldin C, Stone-Elander S, Sedvall G. PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride. Psychopharmacology. 92: 278-84. PMID 2957716 DOI: 10.1007/BF00210831  1
1987 Sedvall G, Farde L, Wiesel FA. Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients. Life Sciences. 41: 813-6. PMID 2956473 DOI: 10.1016/0024-3205(87)90169-X  1
1987 Farde L, Wiesel FA, Hall H, Halldin C, Stone-Elander S, Sedvall G. No D2 receptor increase in PET study of schizophrenia. Archives of General Psychiatry. 44: 671-2. PMID 2955770 DOI: 10.1001/archpsyc.1987.01800190091013  1
1987 Sedvall G, Nybäck H, Farde L, Persson A. Neurotransmitter receptor imaging in Alzheimer's disease. Journal of Neural Transmission. Supplementum. 24: 43-8. PMID 2824693  1
1986 Halldin C, Stone-Elander S, Farde L, Ehrin E, Fasth KJ, LÃ¥ngström B, Sedvall G. Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 37: 1039-43. PMID 3027000  1
1986 Sedvall G, Farde L, Persson A, Wiesel FA. Imaging of neurotransmitter receptors in the living human brain. Archives of General Psychiatry. 43: 995-1005. PMID 3019270  1
1986 Sedvall G, Farde L, Stone-Elander S, Halldin C. Dopamine D1-receptor binding in the living human brain. Advances in Experimental Medicine and Biology. 204: 119-24. PMID 2947423  1
1986 Wik G, Wiesel FA, Eneroth P, Sedvall G, Aström G. Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment. Acta Psychiatrica Scandinavica. 74: 161-7. PMID 2877544  0.68
1986 Farde L, Hall H, Ehrin E, Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science (New York, N.Y.). 231: 258-61. PMID 2867601  1
1985 Bjerkenstedt L, Edman G, Flyckt L, Hagenfeldt L, Sedvall G, Wiesel FA. Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor--a dose-response study in depressed patients. Psychopharmacology. 87: 253-9. PMID 3936081  0.68
1985 Ehrin E, Farde L, de Paulis T, Eriksson L, Greitz T, Johnström P, Litton JE, Nilsson JL, Sedvall G, Stone-Elander S. Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. The International Journal of Applied Radiation and Isotopes. 36: 269-73. PMID 3874833  1
1985 Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedström CG, Litton JE, Sedvall G. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proceedings of the National Academy of Sciences of the United States of America. 82: 3863-7. PMID 3873656  1
1985 Persson A, Ehrin E, Eriksson L, Farde L, Hedström CG, Litton JE, Mindus P, Sedvall G. Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. Journal of Psychiatric Research. 19: 609-22. PMID 3001301  1
1985 Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA. Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. The British Journal of Psychiatry : the Journal of Mental Science. 147: 276-82. PMID 2415198  0.68
1984 Härnryd C, Bjerkenstedt L, Björk K, Gullberg B, Oxenstierna G, Sedvall G, Wiesel FA, Wik G, Aberg-Wistedt A. Clinical evaluation of sulpiride in schizophrenic patients--a double-blind comparison with chlorpromazine. Acta Psychiatrica Scandinavica. Supplementum. 311: 7-30. PMID 6367364  0.68
1984 Sedvall G, Iselius L, Nybäck H, Oreland L, Oxenstierna G, Ross SB, Wiesel FA. Genetic studies of CSF monoamine metabolites. Advances in Biochemical Psychopharmacology. 39: 79-85. PMID 6205565  0.68
1984 Beck O, Borg S, Edman G, Fyrö B, Oxenstierna G, Sedvall G. 5-hydroxytryptophol in human cerebrospinal fluid: conjugation, concentration gradient, relationship to 5-hydroxyindoleacetic acid, and influence of hereditary factors. Journal of Neurochemistry. 43: 58-61. PMID 6202846  0.36
1984 Härnryd C, Bjerkenstedt L, Gullberg B, Oxenstierna G, Sedvall G, Wiesel FA. Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patients. Acta Psychiatrica Scandinavica. Supplementum. 311: 75-92. PMID 6199950  0.68
1984 Alfredsson G, Bjerkenstedt L, Edman G, Härnryd C, Oxenstierna G, Sedvall G, Wiesel FA. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine. Acta Psychiatrica Scandinavica. Supplementum. 311: 49-74. PMID 6199949  0.68
1984 Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA. Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. Journal of Neurochemistry. 42: 833-7. PMID 6198473  0.68
1984 Farde L, Sedvall G. [Swedish research in frontline. Positron emission tomography shows the brain's receptor functions in psychiatric diseases]. LäKartidningen. 81: 4519-21. PMID 6097782  1
1984 Ehrin E, Johnström P, Stone-Elander S, Nilsson JL, Persson A, Farde L, Sedvall G, Litton JE, Eriksson L, Widén L. Preparation and preliminary positron emission tomography studies of 11C-Ro 15-1788, a selective benzodiazepine receptor antagonist. Acta Pharmaceutica Suecica. 21: 183-8. PMID 6093432  1
1983 Swahn CG, Sedvall G. Identification and determination of 1-methylimidazole-4-acetic acid in human cerebrospinal fluid by gas chromatography-mass spectrometry. Journal of Neurochemistry. 40: 688-96. PMID 6827268  0.92
1983 Beck O, Borg S, Sedvall G. Tryptophan levels in human cerebrospinal fluid after acute and chronic ethanol consumption. Drug and Alcohol Dependence. 12: 217-22. PMID 6653393 DOI: 10.1016/0376-8716(83)90063-7  1
1983 Borg S, Kvande H, Mossberg D, Valverius P, Sedvall G. Central nervous system noradrenaline metabolism and alcohol consumption in man. Pharmacology, Biochemistry, and Behavior. 18: 375-8. PMID 6634849  0.36
1983 Borg S, Czarnecka A, Kvande H, Mossberg D, Sedvall G. Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal. Alcoholism, Clinical and Experimental Research. 7: 411-5. PMID 6362467  0.36
1983 Nybäck H, Berggren BM, Hindmarsh T, Sedvall G, Wiesel FA. Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers. Psychiatry Research. 9: 301-8. PMID 6196802  0.68
1983 Widen L, Blomqvist G, Greitz T, Litton JE, Bergström M, Ehrin E, Ericson K, Eriksson L, Ingvar DH, Johansson L, Nilsson JL, Stone-Elander S, Sedvall G, Wiesel F, Wiik G. PET studies of glucose metabolism in patients with schizophrenia. Ajnr. American Journal of Neuroradiology. 4: 550-2. PMID 6136180  1
1982 Wiesel FA, Alfredsson G, Ehrnebo M, Sedvall G. Prolactin response following intravenous and oral sulpiride in healthy human subjects in relation to sulpiride concentrations. Psychopharmacology. 76: 44-7. PMID 6805007  0.68
1982 Wiesel FA, Fyrö B, Nybäck H, Sedvall G, Wode-Helgodt B. Relationships in healthy volunteers between secretion of monoamine metabolites in urine, and family history of psychiatric morbidity. Biological Psychiatry. 17: 1403-13. PMID 6186299  0.68
1981 Borg S, Kvande H, Sedvall G. Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science (New York, N.Y.). 213: 1135-7. PMID 7268421  1
1980 Wiesel FA, Alfredsson G, Ehrnebo M, Sedvall G. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects. European Journal of Clinical Pharmacology. 17: 385-91. PMID 7418717  0.68
1980 Sedvall G, Fyrö B, Gullberg B, Nybäck H, Wiesel FA, Wode-Helgodt B. Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. The British Journal of Psychiatry : the Journal of Mental Science. 136: 366-74. PMID 6155965  0.68
1980 Mathé AA, Sedvall G, Wiesel FA, Nybäck H. Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophrenia. Lancet. 1: 16-8. PMID 6101355  0.68
1979 Alfredsson G, Sedvall G, Wiesel FA. Quantitative analysis of sulpiride in body fluids by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography. 164: 187-93. PMID 541409  0.68
1979 Swahn CG, Beving H, Sedvall G. Mass fragmentographic determination of 4-amino-3-p-chlorophenylbutyric acid (baclofen) in cerebrospinal fluid and serum. Journal of Chromatography. 162: 433-8. PMID 528610  0.92
1978 Frankenhaeuser M, von Wright MR, Collins A, von Wright J, Sedvall G, Swahn CG. Sex differences in psychoneuroendocrine reactions to examination stress. Psychosomatic Medicine. 40: 334-43. PMID 684135  0.92
1978 Wode-Helgodt B, Borg S, Fyrö B, Sedvall G. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine. Acta Psychiatrica Scandinavica. 58: 149-73. PMID 358755  0.36
1977 Sedvall G, Bjerkenstedt L, Swahn CG, Wiesel FA, Wode-Helgodt B. Mass fragmentography to study dopamine metabolism. Advances in Biochemical Psychopharmacology. 16: 343-8. PMID 883547  0.92
1977 Alfredsson G, Wiesel FA, Fyro B, Sedvall G. Mass fragmentographic analysis of clomipramine and its mono-demethylated metabolite in human plasma. Psychopharmacology. 52: 25-30. PMID 403553  0.68
1977 Beck O, Wiesel FA, Sedvall G. Mass fragmentographic determination of 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid in brain tissue using deuterated internal standards. Journal of Chromatography. 134: 407-14. PMID 140179  0.68
1975 Sedvall G, Fyrö B, Nybäck H, Wiesel FA. Actions of dopaminergic antagonists in the striatum. Advances in Neurology. 9: 131-40. PMID 238375  0.68
1975 Wiesel FA, Sedvall G. Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat. European Journal of Pharmacology. 30: 364-7. PMID 236193  0.68
1974 Fri CG, Wiesel FA, Sedvall G. Mass fragmentographic analysis of homovanillic acid and its homoiso analogue in cerebrospinal fluid using the alpha-dideutero acid as internal standard. Psychopharmacologia. 35: 295-304. PMID 4831514  0.68
1974 Fyrö B, Wode-Helgodt B, Borg S, Sedvall G. The effect of chlorpromazine on homovanillic acid levels in cerebrospinal fluid of schizophrenic patients. Psychopharmacologia. 35: 287-94. PMID 4831513  0.36
1974 Fri CG, Wiesel FA, Sedvall G. Simultaneous quantification of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid by mass fragmentography. Life Sciences. 14: 2469-80. PMID 4549970  0.68
1974 Sedvall G, Fyrö B, Nybäck H, Wiesel FA, Wode-Helgodt B. Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs. Journal of Psychiatric Research. 11: 75-80. PMID 4461807  0.68
1974 Wiesel FA, Fri CG, Sedvall G. Simultaneous mass fragmentographic determination of 3, 4-dihydroxyphenylacetic acid and 4 hydroxy-3-methoxyphenylacetic acid in brain tissue. Journal of Neural Transmission. 35: 319-26. PMID 4436671  0.68
1974 Wiesel FA, Sedvall G. Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass fragmentography. Brain Research. 65: 547-50. PMID 4415145  0.68
1973 Wiesel FA, Fri CG, Sedvall G. Determination of homovanillic acid turnover in rat striatum using a monoamine oxidase inhibitor. European Journal of Pharmacology. 23: 104-6. PMID 4733765  0.68
1967 Ngai SH, Rosell S, Sedvall G. Influence of hypercapnia on the noradrenalin content of sympathetically decentralized and innervated skeletal muscle. Experientia. 23: 394-5. PMID 6065787  0.44
1965 FUXE K, SEDVALL G. THE DISTRIBUTION OF ADRENERGIC NERVE FIBRES TO THE BLOOD VESSELS IN SKELETAL MUSCLE. Acta Physiologica Scandinavica. 64: 75-86. PMID 14347281 DOI: 10.1111/j.1748-1716.1965.tb04155.x  1
1965 Sedvall G, Thorson J. Adrenergic transmission at vasoconstrictor nerve terminals partially depleted of noradrenaline. Acta Physiologica Scandinavica. 64: 251-8. PMID 5855022 DOI: 10.1111/j.1748-1716.1965.tb04175.x  1
1965 Dahlström A, Fuxe K, Kernell D, Sedvall G. Reduction of the monoamine stores in the terminals of bulbospinal neurones following stimulation in the medulla oblongata. Life Sciences. 4: 1207-12. PMID 5840099  1
Show low-probability matches.